Literature DB >> 20083893

A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues.

Ayelet Avraham1, Judith Sandbank, Nirit Yarom, Avshalom Shalom, Tami Karni, Itzhak Pappo, Avishay Sella, Alexander Fich, Shlomo Walfisch, Larisa Gheber, Ella Evron.   

Abstract

HOX genes are developmental genes that determine anterior-posterior embryonic pattern and govern the process of differentiation. Inappropriate expression of HOX genes has been implicated in developmental abnormalities and hematopoietic malignancies. In addition, HOX genes silencing by DNA methylation has been reported in cancers and related to disease aggressiveness and outcome. On the other hand, accumulating evidence suggests that epigenetic changes at HOX genes are linked to normal development and differentiation. To better understand the relationship between HOXA methylation and cancer, we analyzed the methylation pattern of HOXA genes in human primary breast and colon carcinomas, normal tissues, and normal white blood cells. Genome-wide methylation arrays of breast cancers and white blood cells demonstrated similar methylation patterns. Quantitative methylation analysis of seven representative HOXA genes revealed various levels of methylation in both normal tissues and cancers. Analysis of epithelial-enriched normal breast tissue and stroma indicated that the stroma was the major origin of HOXA methylation. Furthermore, in selected dense breast cancers, minimal increase in methylation of several HOXA genes did not correlate with the predominance of malignant epithelial cells in these tumors. Our results suggest that methylation of the HOXA cluster may be a normal developmental and cell type specific process rather than a cancer specific mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083893     DOI: 10.4161/epi.5.1.10724

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  7 in total

1.  DNA methylation analysis of Homeobox genes implicates HOXB7 hypomethylation as risk factor for neural tube defects.

Authors:  Anne Rochtus; Benedetta Izzi; Elise Vangeel; Sophie Louwette; Christine Wittevrongel; Diether Lambrechts; Yves Moreau; Raf Winand; Carla Verpoorten; Katrien Jansen; Chris Van Geet; Kathleen Freson
Journal:  Epigenetics       Date:  2015-01-29       Impact factor: 4.528

2.  Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.

Authors:  Ayelet Avraham; Sean Soonweng Cho; Ronit Uhlmann; Mia Leonov Polak; Judith Sandbank; Tami Karni; Itzhak Pappo; Ruvit Halperin; Zvi Vaknin; Avishay Sella; Saraswati Sukumar; Ella Evron
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

3.  Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer.

Authors:  Bingshu Xia; Ming Shan; Ji Wang; Zhenbin Zhong; Jingshu Geng; Xiaohui He; Tung Vu; Dekai Zhang; Da Pang
Journal:  Oncotarget       Date:  2017-02-07

4.  Silencing long non-coding RNA HOTAIR exerts anti-oncogenic effect on human acute myeloid leukemia via demethylation of HOXA5 by inhibiting Dnmt3b.

Authors:  Si-Li Wang; Yun Huang; Rui Su; Yong-Yang Yu
Journal:  Cancer Cell Int       Date:  2019-04-29       Impact factor: 5.722

5.  DNA methylation and differentiation: HOX genes in muscle cells.

Authors:  Koji Tsumagari; Carl Baribault; Jolyon Terragni; Sruti Chandra; Chloe Renshaw; Zhiyi Sun; Lingyun Song; Gregory E Crawford; Sriharsa Pradhan; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenetics Chromatin       Date:  2013-08-02       Impact factor: 4.954

6.  Increased methylation and decreased expression of homeobox genes TLX1, HOXA10 and DLX5 in human placenta are associated with trophoblast differentiation.

Authors:  Boris Novakovic; Thierry Fournier; Lynda K Harris; Joanna James; Claire T Roberts; Hannah E J Yong; Bill Kalionis; Danièle Evain-Brion; Peter R Ebeling; Euan M Wallace; Richard Saffery; Padma Murthi
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379

7.  Discovery of novel DNA methylation biomarkers for non-invasive sporadic breast cancer detection in the Latino population.

Authors:  Mónica Cappetta; Lucía Fernandez; Lucía Brignoni; Nora Artagaveytia; Carolina Bonilla; Miguel López; Manel Esteller; Bernardo Bertoni; María Berdasco
Journal:  Mol Oncol       Date:  2020-11-19       Impact factor: 7.449

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.